PUNE, India, November 9, 2015 /PRNewswire/ --
While China, India and Japan lead Asian markets, the European radioimmunoassay market contributed the largest share in the global market, and was valued at $121.5 million in 2014. It is projected to reach $154.6 million by 2020, at a CAGR of 3.9% during the given forecast period.
Complete report on radioimmunoassay market spread across 113 pages, profiling 13 major companies and supported with 75 tables and 68 figures is now available at http://www.lifescienceindustryresearch.com/radioimmunoassay-market-by-type-reagents-kits-analyzers-end-user-hospital-pharmaceutical-industry-academics-clinical-diagnostic-labs-application-research-clinical-diagnostics-and-geogr.html .
The global radioimmunoassay (RIA) market constituted 2.3% share of the global immunoassay market. Radioimmunoassay also has it application in the research purpose, and contributed a share of 65.9% to the overall radioimmunoassay market in 2014. The global radioimmunoassay market is expected to reach $428.4 million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020. The growing aging population and rise in the usage of radioimmunoassay technique in Oncology are the major factors influencing this market.
There are various application areas for RIA in research and diagnostics, which are infectious disease testing, endocrine testing, allergy testing, oncology testing, toxicology testing, and autoimmune disease testing. Out of all the application segments, oncology testing is the largest application segment, and is expected to hold the largest market share in the near future. The major reason behind these is the growth in the oncology market due to various factors, such as the increasing incidence rate of cancer, growth in aging population, urbanization with heavy pollution, and others.
The global radioimmunoassay market report studies the major regions, namely, North America, Europe, Asia, and the Rest of the World (RoW). In 2015, Europe is estimated to account for the largest share of 35.1% in the global radioimmunoassay market. As radioimmunoassay is one of the key instruments used in the life sciences sector, increased investments in life sciences are expected to fuel the growth of the radioimmunoassay market in the region. However, the growth in the European radioimmunoassay market is driven by the outsourcing of drug discovery, rising government investments in life sciences, and increasing prevalence of infectious diseases as well as cancer in this region.
From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities of the global Radioimmunoassay (RIA) market.
The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are DIAsource Immuno Assays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany) among others. Order a copy of Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020 research report at http://www.lifescienceindustryresearch.com/purchase?rname=61541 .
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.
For insights on related markets, another research about Immunoassay Market is spread across 305 pages with 352 tables & 40 figures. According to forecasts, the immunoassay market is expected to reach $23,712.4 million by 2019 from $14,926.3 million in 2014, at a CAGR of 9.7% from 2014 to 2019. This market is categorized on the basis of technology, products and services, applications, end users, and regions available at http://www.lifescienceindustryresearch.com/immunoassay-market-by-technology-elisa-fluorescence-colorimetric-chemiluminescence-rapid-test-western-blot-elispot-pcr-application-infectious-disease-endocrinology-cardiology-oncology-h.html .
LifeScienceIndustryResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus: https://plus.google.com/112612135957880308475/about
RSS / Feeds: http://www.lifescienceindustryresearch.com/feed/
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
SOURCE Life Science Industry Research